The Paul, Weiss Litigation Department is led by a team of the country’s most accomplished trial lawyers. Our litigators handle the most complex and demanding lawsuits, class actions, government investigations, criminal prosecutions and restructurings. Our clients include Fortune 50 corporations and other prominent companies in the financial services, investment, medical device, pharmaceutical, sports, technology, energy, media and insurance industries. Every day, we are called on by chief executives, board chairs, general counsel, investors and entrepreneurs for our unmatched trial skills, sophisticated business judgment and renowned strategic advice.
Second Circuit Review: Court Holds Environmental Group Has Standing to Challenge FDA’s Inaction
April 24, 2013 download PDF
Litigation partners Martin Flumenbaum and Brad Karp's Second Circuit Review column appeared in the April 24 issue of the New York Law Journal. The article, "Court Holds Environmental Group Has Standing to Challenge FDA's Inaction," examines Natural Resources Defense Council v. U.S. Food and Drug Administration, in which the U.S. Court of Appeals for the Second Circuit vacated and remanded the district court's decision granting summary judgment to the Food and Drug Administration (FDA). Litigation associate Danielle Polebaum assisted in the preparation of this column.